An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study
Authors:
Open Access
- 9 September 2023
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 64, 102200
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA008748, P50 CA140146)
This publication has 47 references indexed in Scilit:
- Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohortsThe Lancet Oncology, 2012
- Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysisWorld Journal of Surgical Oncology, 2012
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysisThe Lancet Oncology, 2009
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trialThe Lancet, 2009
- Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular MarkersThe American Statistician, 2008
- Risk stratification of patients diagnosed with gastrointestinal stromal tumorHuman Pathology, 2008
- Which Is the Optimal Risk Stratification System for Surgically Treated Localized Primary GIST? Comparison of Three Contemporary Prognostic Criteria in 171 Tumors and a Proposal for a Modified Armed Forces Institute of Pathology Risk CriteriaAnnals of Surgical Oncology, 2008
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant TherapyAnnals of Surgical Oncology, 2004